Implications of Preoperative Transbronchial Lung Biopsy for Non-small Cell Lung Cancer Less than 3-cm

MOTOAKI YASUKAWA; TAKESHI KAWAGUCHI; MICHITAKA KIMURA; TAKASHI TOJO; SHIGEKI TANIGUCHI

doi:10.21873/invivo.12346

Research ArticleClinical Studies

Implications of Preoperative Transbronchial Lung Biopsy for Non-small Cell Lung Cancer Less than 3-cm

MOTOAKI YASUKAWA, TAKESHI KAWAGUCHI, MICHITAKA KIMURA, TAKASHI TOJO and SHIGEKI TANIGUCHI

In Vivo March 2021, 35 (2) 1027-1031; DOI: https://doi.org/10.21873/invivo.12346

MOTOAKI YASUKAWA

1Department of Thoracic and Cardiovascular Surgery, Nara Medical University School of Medicine, Nara, Japan;

2Department of Surgery, Osaka Kaisei Hospital, Osaka, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: mo_yasukawa@hotmail.com

TAKESHI KAWAGUCHI

1Department of Thoracic and Cardiovascular Surgery, Nara Medical University School of Medicine, Nara, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

MICHITAKA KIMURA

3Department of Thoracic Surgery, Saiseikai Chuwa Hospital, Nara, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

TAKASHI TOJO

3Department of Thoracic Surgery, Saiseikai Chuwa Hospital, Nara, Japan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

SHIGEKI TANIGUCHI

1Department of Thoracic and Cardiovascular Surgery, Nara Medical University School of Medicine, Nara, Japan;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
PDF

Article Figures & Data

Figures

Tables

Download figure
Open in new tab
Download powerpoint
Figure 1.
Overall survival curves for all patients according to transbronchial lung biopsy (TBLB). The 5-year overall survival rates were 88.5% in the TBLB group and 94.7% in the Non-TBLB group (p=0.056).
Download figure
Open in new tab
Download powerpoint
Figure 2.
Recurrence-free survival curves for all patients according to transbronchial lung biopsy (TBLB). The 5-year recurrence-free survival rates were 75.5% in the TBLB group and 91.4% in the Non-TBLB group (p<0.001).

Tables

Figures

PreviousNext

In this issue

In Vivo

Vol. 35, Issue 2

March-April 2021

Table of Contents
Table of Contents (PDF)
Index by author
Back Matter (PDF)
Ed Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Implications of Preoperative Transbronchial Lung Biopsy for Non-small Cell Lung Cancer Less than 3-cm

Message Subject (Your Name) has sent you a message from In Vivo

Message Body (Your Name) thought you would like to see the In Vivo web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 11 + 9 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.